Late-Stage Active Oncology Drug Developers | An Overview
March 9, 2023
Join our Premium Membership and unlock all content for unlimited access.
US State - Alaska US State - Alaska
Takeda Oncology (Millennium Pharmaceuticals, Inc) is a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, developing therapies for the treatment...
. SERINE / THEONINE KINASE INHIBITORS 1. BRAF/MEK/ERK Inhibitors 2. CDK Inhibitors 3. PI3K/AKT/mTOR Inhibitors Check Also KINASE INHIBITORS -...
. SERINE / THEONINE KINASE INHIBITORS 1. BRAF/MEK/ERK Inhibitors 2. CDK Inhibitors 3. PI3K/AKT/mTOR Inhibitors Check Also KINASE INHIBITORS -...
. NON-RECEPTOR TYROSINE KINASE INHIBITORS 1. Bcr-Abl1 Inhibitors 2. JAK Inhibitors 3. BTK Inhibitors Check Also KINASE INHIBITORS - An...
Protein kinases are the enzymes that catalyzes the transfer of γ-phosphate group from ATP to protein residues containing hydroxyl groups...
updated.. easy.. precise... complete...
Presenting filtered comprehensive information. Gain more insights on emerging bio-business, frame strategies, grow faster & better connect with biological science community.
LEARN MORE »
Developed by OmicsX. The entirety of this site is protected by copyright © 2010–2021 HH BioTechnologies Private Ltd.
Developed by OmicsX. The entirety of this site is protected by copyright © 2010–2021 HH BioTechnologies Private Ltd.